Who can take part?
Patients with metastatic hormone-sensitive prostate cancer (mHSPC).
What is involved for you?
Participation in this study may continue for 4.5 years. It will involve seeing the doctor and coordinator for study visits every 2-4 weeks for physical exams, ECG's, blood tests, tumour assessments (ie-CT scans). You will be required to take oral medicine most days of the study, and do some self assessments of your side effects.